The market for the popular weight loss drug Wegovy (semaglutide) is expanding after Novo Nordisk, the Denmark-based pharmaceutical giant that manufactures it, issued new claims that the controversial pharmaceutical injection supposedly also helps to prevent heart attack, stroke and early death. Conveniently for the company, Wegovy allegedly works against a variety of cardiovascular problems that just so … Continue reading Novo Nordisk makes absurd new health claims about Wegovy weight loss medication, which is synthesized based on REPTILIAN venom peptides
Diabetes and obesity drugs linked to thyroid cancer
The European Medicines Agency (EMA), the European Union's (EU) version of the Food and Drug Administration (FDA), issued a drug safety signal this week about the elevated thyroid cancer risk associated with certain classes of pharmaceuticals for Type 2 diabetes and obesity. Semaglutide, the active ingredient found in the widely used anti-diabetes and anti-obesity drugs Ozempic and … Continue reading Diabetes and obesity drugs linked to thyroid cancer
Americans consume half the global supply of diabetes drugs
It is no secret that the United States is an exceptionally fat country – one of the fattest in the world, in fact. It thus makes sense that nearly half of all global revenue from the sale of insulin and other diabetes pharmaceutical drugs is generated right here in America. Even though the U.S. represents only about … Continue reading Americans consume half the global supply of diabetes drugs
FDA has granted “emergency-use authorization” to Eli Lilly’s coronavirus antibody treatment
The Food and Drug Administration (FDA) gave Eli Lilly’s antibody drug emergency-use authorization on Monday, Nov. 9. Early data has strongly suggested that the pharmaceutical company’s antibody drug is effective at keeping people with mild to moderate cases of the Wuhan coronavirus (COVID-19) from needing to get admitted to a hospital. The FDA extended the emergency approval to the experimental therapy known … Continue reading FDA has granted “emergency-use authorization” to Eli Lilly’s coronavirus antibody treatment
AstraZeneca begins advanced trials for COVID-19 antibody medication
British pharmaceutical company AstraZeneca has commenced late-stage trials for its COVID-19 antibody drug. In an Oct. 9 statement, the company said that two tests for the AZD7442 long-acting antibody drug, involving 6,000 adult participants worldwide, will look at the medication’s ability to prevent COVID-19 symptoms. A subsequent trial to observe AZD7442’s use as a COVID-19 treatment, involving 4,000 volunteers, … Continue reading AstraZeneca begins advanced trials for COVID-19 antibody medication
Eli Lilly monoclonal antibody drug trial paused over safety concerns
Eli Lilly & Company are halting the enrollment of participants in a clinical trial of its antibody treatment for the Wuhan coronavirus (COVID-19) due to safety concerns. According to company spokeswoman Molly McCully, an independent data and safety monitoring board (DSMB) had recommended pausing enrollment in the U.S. government-sponsored trials. Lilly, however, did not say what caused the panel … Continue reading Eli Lilly monoclonal antibody drug trial paused over safety concerns
Dr. Eddy Bettermann MD 